BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $588,350 | -41.7% | 205,000 | +2.5% | 0.14% | -39.3% |
| Q2 2023 | $1,010,000 | +74.3% | 200,000 | -34.8% | 0.24% | +109.6% |
| Q1 2023 | $579,491 | +2.2% | 306,609 | -2.7% | 0.11% | -2.6% |
| Q4 2022 | $567,000 | -4.2% | 315,000 | -10.0% | 0.12% | -10.0% |
| Q3 2022 | $592,000 | -53.7% | 350,000 | -32.7% | 0.13% | -46.3% |
| Q2 2022 | $1,279,000 | – | 520,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |